1. Home
  2. RFIL vs LPCN Comparison

RFIL vs LPCN Comparison

Compare RFIL & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RF Industries Ltd.

RFIL

RF Industries Ltd.

HOLD

Current Price

$5.92

Market Cap

63.0M

Sector

Technology

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$6.65

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RFIL
LPCN
Founded
1979
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.0M
13.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RFIL
LPCN
Price
$5.92
$6.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.25
$7.00
AVG Volume (30 Days)
50.6K
118.6K
Earning Date
01-15-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,353,000.00
$4,322,693.00
Revenue This Year
$21.53
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.60
N/A
52 Week Low
$3.39
$2.52
52 Week High
$9.56
$6.72

Technical Indicators

Market Signals
Indicator
RFIL
LPCN
Relative Strength Index (RSI) 40.96 92.60
Support Level $5.60 $4.07
Resistance Level $6.09 $6.72
Average True Range (ATR) 0.28 0.51
MACD 0.03 0.32
Stochastic Oscillator 28.75 92.86

Price Performance

Historical Comparison
RFIL
LPCN

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: